Methanesulfonates: the relationship of structure to antitumor activity.
D000230:Adenocarcinoma / Q000188:drug therapy; D000438:Alcohols / Q000627:therapeutic use; D000476:Alkanesulfonates / Q000627:therapeutic use*; D000478:Alkylation; D000588:Amines / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002241:Carbohydrates; D002277:Carcinoma / Q000188:drug therapy; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D003500:Cyclization; D007939:Leukemia L1210 / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D051379:Mice; D009584:Nitrogen / Q000627:therapeutic use; D009705:Nucleosides / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy; D013256:Steroids / Q000627:therapeutic use; D013329:Structure-Activity Relationship
D000438:Alcohols; D000476:Alkanesulfonates; D000588:Amines; D000970:Antineoplastic Agents; D002241:Carbohydrates; D009705:Nucleosides; D010879:Piperazines; D013256:Steroids; D009584:Nitrogen